Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Return on Capital Employed (2016 - 2026)

Mimedx's Return on Capital Employed history spans 15 years, with the latest figure at 14.08% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed fell 993.0% to 14.08% in Q1 2026 year-over-year; TTM through Mar 2026 was 14.08%, a 993.0% decrease, with the full-year FY2025 number at 26.73%, down 186.0% from a year prior.
  • Return on Capital Employed hit 14.08% in Q1 2026 for Mimedx, down from 23.97% in the prior quarter.
  • Over the last five years, Return on Capital Employed for MDXG hit a ceiling of 34.03% in Q2 2024 and a floor of 19.82% in Q3 2022.
  • Historically, Return on Capital Employed has averaged 13.24% across 5 years, with a median of 21.78% in 2025.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 4350bps in 2023 and later crashed -1544bps in 2025.
  • Tracing MDXG's Return on Capital Employed over 5 years: stood at 11.46% in 2022, then skyrocketed by 293bps to 22.09% in 2023, then rose by 28bps to 28.26% in 2024, then fell by -15bps to 23.97% in 2025, then plummeted by -41bps to 14.08% in 2026.
  • Business Quant data shows Return on Capital Employed for MDXG at 14.08% in Q1 2026, 23.97% in Q4 2025, and 21.78% in Q3 2025.